Blanco R, Domine M, Gonzalez JL, Loutfi S, et al. Pembrolizumab as first-line treatment for advanced NSCLC in older adults: A phase II clinical trial evaluating geriatric and quality-of-life outcomes. Lung Cancer 2023;183:107318.
PMID: 37557022